Capricor Therapeutics
CAPR
CAPR
30 hedge funds and large institutions have $10M invested in Capricor Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $18.1M → $10M (-$8.07M)
46% less call options, than puts
Call options by funds: $1.18M | Put options by funds: $2.21M
Holders
30
Holding in Top 10
–
Calls
$1.18M
Puts
$2.21M
Top Buyers
| 1 | +$222K | |
| 2 | +$190K | |
| 3 | +$180K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$168K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$115K |
Top Sellers
| 1 | -$5.98M | |
| 2 | -$221K | |
| 3 | -$171K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$85K |
| 5 |
Millennium Management
New York
|
-$69K |